medline.ch Onkologie Respirationstrakt

	Survival study of cytoreductive prostatectomy for prostate cancer with lung metastasis: A propensity score matching study based on the SEER database. PLoS One Xiang AP, Yuan XF, Qin ZQ. PMID: 41729968 [PubMed - indexed for MEDLINE]
	EfficientNetB7-Based Deep Learning Framework for Enhanced Classification of Lung and Colon Cancer Histopathological Images. J Vis Exp Aditya PH, Mahesh TR, Jeyan JVML, Bhatia Khan S, Basheer S, Algarni A. PMID: 41729802 [PubMed - indexed for MEDLINE]
	A Nursing Intervention Combining Case Management and CBT for Postoperative NSCLC Patients: Effects on Anxiety, Depression, and Quality of Life. J Vis Exp Liu Y, Sun Y, Chen N. PMID: 41729760 [PubMed - indexed for MEDLINE]
	Clinical efficacy and safety of robotic-assisted thoracic surgery after neoadjuvant therapy in non-small cell lung cancer: a systematic review and meta-analysis. Updates Surg Liang G, Peng H, Li Y. PMID: 41729427 [PubMed - as supplied by publisher]
	Intracranial efficacy of systemic therapies for patients with ALK-positive non-small cell lung cancer in patients with brain metastases: a systematic review and meta-analysis. J Chemother Hernandez DA, Petersen G, Gonzalez-Salido J, Lopez J, Diaz Garcia DA. PMID: 41728837 [PubMed - as supplied by publisher]
	Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis. Drug Des Devel Ther Xu H, Du Z, Shui J, Li X, Tang J, Li G. PMID: 41728357 [PubMed - indexed for MEDLINE]
	Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review. Ann Glob Health de la Pava-Cortés C, Peña Torres E, Driscoll T, Jones C, Coles J, McArdle S, Brislane K, Peters M, Villamizar G, Algranti E, Frank A. PMID: 41728043 [PubMed - indexed for MEDLINE]
	The role of antibody-drug conjugates in the treatment of lung cancer. Front Oncol Zlatanova T, Changalova A, Janzic U. PMID: 41727667 [PubMed]
	The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer. Front Public Health Yan X, Zhou S, Hu J, Xia Y, He H, Jovanoski N, Arnold M, Hu J, Song P, Jiang B, Zhang Y, Lu J, Wu Y, Ying X. PMID: 41726776 [PubMed - indexed for MEDLINE]
	Automating Lung-RADS Categorization And Follow-Up Recommendations Using In-Context Learning With Large Language Models. AMIA Annu Symp Proc Zhou T, Chen A, Hu Y, Lou X, He X, Huang Y, Hochhegger B, Mehta H, Prosperi M, Guo Y, Bian J. PMID: 41726431 [PubMed - indexed for MEDLINE]
	Clinical outcomes and safety of continuous immunotherapy beyond progression in patients with extensive-stage small cell lung cancer: a retrospective real-world study. Front Immunol Wang C, Xuan T, Wang Y, Yang C, Zhao W, Zhang R, Meng X, Li J. PMID: 41726183 [PubMed - indexed for MEDLINE]
	AI-Enhanced 4D CT Radiotherapy Planning for Personalized Lung Cancer Treatment with Respiratory Motion Management. Indian J Surg Oncol Trabelsi M, Ben Salem L, Romdhane H, Ben-Sellem D. PMID: 41726011 [PubMed]
	The Association Between Health-Related Quality of Life Scores and Clinical Outcomes for People Living With Lung Cancer: An Australian Registry Cohort Study Using Patient-Reported Outcomes to Drive Value-Based Healthcare. Thorac Cancer Harden SV, King MT, Li JJ, Tissera S, Lloyd M, Briggs L, Wood T, Billah B, Samankula D, Smith S, Brand M, Lang T, Parente P, McGrath S, Langton D, Dumnall T, Jennings B, Nicholls S, Stirling RG, Richardson G, Zalcberg J. PMID: 41725517 [PubMed - indexed for MEDLINE]
	External Validation of The Proliferation Saturation Index Model in Predicting Tumour Volume Regression in Patients with Non-Small Cell Lung Cancer Undergoing Radiation Therapy. Int J Radiat Oncol Biol Phys Barrett S, Zahid M, McGarry CK, Enderling H, Walls GM, Marignol L. PMID: 41724248 [PubMed - as supplied by publisher]
	Comparison of long-term survival between nivolumab plus ipilimumab with chemotherapy and pembrolizumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study. Lung Cancer Kinehara Y, Matsumoto K, Shiroyama T, Komuta K, Tamiya M, Nishino K, Tamiya A, Kuge T, Uchida J, Suzuki H, Yamamoto S, Tobita S, Niki T, Tetsumoto S, Morimura O, Osa A, Minami T, Nagatomo I, Takeda Y, Kijima T, Kumanogoh A. PMID: 41723915 [PubMed - as supplied by publisher]
	Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study). Lung Cancer Stensland EM, Stensgaard S, Eide IJZ, Nilssen Y, Horndalsveen H, Cicenas S, Grønberg BH, Ekman S, Hansen KH, Sorensen BS, Brustugun OT. PMID: 41723914 [PubMed - as supplied by publisher]
	Economic burden of advanced non-small cell lung cancer (NSCLC): a systematic literature review. J Med Econ Jovanoski N, Kaur G, Shukla H, Chana N, Kharawala S. PMID: 41723781 [PubMed - indexed for MEDLINE]
	National Screening, National Responsibility: Turning Promise Into Progress for Lung Cancer Care. Med J Aust Brims FJ. PMID: 41723710 [PubMed - indexed for MEDLINE]
	The Histone-Modified Landscape: Core Mechanisms of Osimertinib Resistance in EGFR-Mutant Lung Cancer. Cancer Lett Yang J, Zhang M, Gao C, Yao X, Sun C, Zhuang J. PMID: 41722838 [PubMed - as supplied by publisher]
	QVT score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy. J Immunother Cancer Chae YK, Velcheti V, Zhang K, Hiremath A, Chung LI, Haji-Maghsoudi O, Chitalia R, Lee J, Li H, Lee S, Mutha P, Nagabhushan R, Levy D, Cantor D, Kim Y, Cheung T, Kim H, Gupta A, Arul T, Madabhushi A, Braman N. PMID: 41720608 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 156568

Seite 1 von 7829

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung